Mumbai: Godrej Industries Limited, along with group entities Godrej Agrovet Limited and Astec LifeSciences Limited, has unveiled a series of leadership changes as part of a structured succession plan, according to a regulatory filing on Monday.
At the group level, Pirojsha Godrej has been named Chairperson Designate and will assume charge as Chairperson of Godrej Industries Group and Godrej Industries Limited effective August 14, 2026. He will continue in his existing leadership roles as Chairperson of Godrej Properties, Godrej Capital, and Godrej Ventures. Commenting on the transition, Pirojsha described the moment as both a privilege and a responsibility, emphasising the need to build on the group’s legacy while staying anchored to its core values.
The transition follows the planned stepping down of current Chairperson Nadir Godrej, who will move into the role of Chairman Emeritus upon turning 75 in August 2026. At that time, he will also exit the boards of Godrej Industries Limited, Godrej Agrovet, Godrej Consumer Products, and Godrej Properties. Reflecting on his tenure, Nadir Godrej said it had been a privilege to serve the group over several decades and expressed confidence in the next generation of leadership to drive continued growth while upholding the organisation’s values.
As part of the broader reshuffle, Burjis Godrej will take over as Chairperson of Godrej Agrovet and will join the board of Godrej Industries Limited as a Non-Executive Director from August 14, 2026. He has stepped down as Managing Director of Astec LifeSciences with immediate effect but will remain associated with the company as a Non-Executive Director. Burjis noted that his focus would be on strengthening Godrej Agrovet’s resilience and delivering sustainable growth through sharper execution.
Leadership changes have also been announced at Astec LifeSciences. Vishal Sharma, currently CEO of Godrej Chemicals, has been appointed Chairperson with immediate effect. Meanwhile, Arijit Mukherjee, who serves as Chief Operating Officer at Astec, will take on the role of Executive Director.
Additionally, Nadir Godrej has already stepped down as Chairperson and Non-Executive Director of Astec LifeSciences effective April 13, 2026, marking the beginning of the transition across group companies.
The succession plan signals a generational shift within the Godrej Group, aimed at ensuring continuity while positioning the conglomerate for its next phase of growth.
